PT99998A - Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2 - Google Patents

Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2

Info

Publication number
PT99998A
PT99998A PT99998A PT9999892A PT99998A PT 99998 A PT99998 A PT 99998A PT 99998 A PT99998 A PT 99998A PT 9999892 A PT9999892 A PT 9999892A PT 99998 A PT99998 A PT 99998A
Authority
PT
Portugal
Prior art keywords
vitamin
dihydroxy
proportional
converted
alpha
Prior art date
Application number
PT99998A
Other languages
English (en)
Other versions
PT99998B (pt
Inventor
Charles W Bishop
Joyce C Knutson
Robert M Moriarty
Raju Penmasta
Stephen Strugnell
Glenville Jones
Liang Guo
Original Assignee
Lunar Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunar Corp filed Critical Lunar Corp
Publication of PT99998A publication Critical patent/PT99998A/pt
Publication of PT99998B publication Critical patent/PT99998B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT99998A 1991-01-08 1992-01-08 Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2 PT99998B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63786791A 1991-01-08 1991-01-08

Publications (2)

Publication Number Publication Date
PT99998A true PT99998A (pt) 1993-01-29
PT99998B PT99998B (pt) 1999-06-30

Family

ID=24557692

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99998A PT99998B (pt) 1991-01-08 1992-01-08 Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2

Country Status (14)

Country Link
US (1) US6211168B1 (pt)
EP (2) EP0550702B1 (pt)
CN (3) CN1032256C (pt)
AT (2) ATE240736T1 (pt)
AU (1) AU1247592A (pt)
DE (2) DE69229103T2 (pt)
DK (1) DK0550702T3 (pt)
ES (2) ES2134207T3 (pt)
GR (1) GR3030466T3 (pt)
MX (1) MX9200070A (pt)
NZ (1) NZ241255A (pt)
PT (1) PT99998B (pt)
WO (1) WO1992012165A1 (pt)
ZA (1) ZA92108B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
EP0614456B1 (en) * 1992-08-28 1999-06-09 Bone Care International, Inc. 1alpha,24(s)-dihydroxy vitamin d2, its formation and use
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US20030129194A1 (en) * 1997-02-13 2003-07-10 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
BR9815442A (pt) 1997-02-13 2001-08-21 Bone Care Int Inc Liberação terapêutica dirigida de compostos de vitamina d
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
ES2368824T3 (es) * 1998-03-27 2011-11-22 Oregon Health & Science University Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
CN1148347C (zh) * 1998-05-29 2004-05-05 骨疗国际公司 羟基-25-烯-维生素d类化合物的制备方法
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
EP1470220B1 (en) 2002-01-10 2011-10-05 Teva Pharmaceutical Industries, Ltd. Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
EP1685099A1 (en) * 2004-07-01 2006-08-02 Teva Pharmaceutical Industries Ltd Crystalline forms of 1,24(s)-dihiyproxy vitamin d2
CN101607931B (zh) * 2009-07-23 2012-01-11 青岛正大海尔制药有限公司 一种骨化三醇的制备方法
CN103122009B (zh) * 2013-01-09 2015-11-25 江苏吉贝尔药业股份有限公司 两种用于合成他卡西醇支链的重要中间体化合物
CN103012463B (zh) * 2013-01-17 2016-02-10 南京理工大学 (s)-3-甲基-2-(叔丁基二甲基硅氧基)-1-溴丁烷的合成方法
CN104496871B (zh) * 2014-12-22 2016-03-09 上海皓元生物医药科技有限公司 一种他卡西醇的制备方法
CN109627279A (zh) * 2019-02-01 2019-04-16 浙江花园营养科技有限公司 一种活性维生素d3中间体的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US467190A (en) * 1892-01-19 Bernard g
US4670190A (en) * 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
US3880894A (en) 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
US3970676A (en) * 1974-10-29 1976-07-20 The Upjohn Company Novel process and intermediate compounds used is preparation of -Δ5,7- steroid dienes
GB1583749A (en) * 1976-06-03 1981-02-04 Res Inst Medicine Chem Vitamin d derivatives
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
US4310511A (en) * 1980-10-02 1982-01-12 Massachusetts General Hospital Sunscreen compositions containing Δ5,7 steroidal dienes
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US4719205A (en) 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4728643A (en) * 1984-11-02 1988-03-01 The General Hospital Corporation Method of treating psoriasis
US4866048A (en) * 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
JPH0755960B2 (ja) * 1986-11-14 1995-06-14 日清製粉株式会社 ステロイド誘導体およびその製造方法
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites

Also Published As

Publication number Publication date
MX9200070A (es) 1992-07-01
CN1078072C (zh) 2002-01-23
EP0550702A1 (en) 1993-07-14
ZA92108B (en) 1992-10-28
DK0550702T3 (da) 1999-11-01
WO1992012165A1 (en) 1992-07-23
DE69229103D1 (de) 1999-06-10
EP0550702B1 (en) 1999-05-06
CN1067243A (zh) 1992-12-23
EP0914825A3 (en) 1999-05-19
EP0550702A4 (en) 1994-06-08
AU1247592A (en) 1992-08-17
ES2134207T3 (es) 1999-10-01
ATE179604T1 (de) 1999-05-15
DE69233074T2 (de) 2004-03-18
DE69233074D1 (de) 2003-06-26
CN1133712A (zh) 1996-10-23
CN1032256C (zh) 1996-07-10
ATE240736T1 (de) 2003-06-15
EP0914825A2 (en) 1999-05-12
CN1071574C (zh) 2001-09-26
PT99998B (pt) 1999-06-30
ES2200238T3 (es) 2004-03-01
GR3030466T3 (en) 1999-10-29
NZ241255A (en) 1999-05-28
DE69229103T2 (de) 1999-10-14
EP0914825B1 (en) 2003-05-21
US6211168B1 (en) 2001-04-03
CN1143500A (zh) 1997-02-26

Similar Documents

Publication Publication Date Title
PT99998A (pt) Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2
NO921955L (no) Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
DK0614456T3 (da) 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse
MX16658A (es) Procedimiento para la preparacion de derivados delacido difosfonico producto obtenido y composicion farmaceutica para el tratamiento de desordenes en el metabolismo del calcio que lo incluye.
ES2052755T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.
DK155686A (da) Parathyroidhormonholdigt praeparat
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
WO1994005630B1 (en) 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE
ATE27456T1 (de) Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
ES2041647T3 (es) Metodo para producir un compuesto de oseinahidroxiapatita.
DE69214617D1 (de) 26,27-Dimethylen-1-Alpha, 25-Dihydroxyvitamin-D2 und 26,27-Dihydroxyvitamin-D2 und Verfahren zu ihrer Herstellung
DK0486561T4 (da) Bukkalt præparat indeholdende S(+)-ketoprofen
AU6814387A (en) Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances
ATE147267T1 (de) Verwendung von 24,25-dihydroxyvitamin-d3 zur herstellung eines arzneimittel zur behandlung der rachitis
MX9300136A (es) Alfa-aril-alfa-hidroxi-beta-imidazolinil-propionamidas, procedimiento para su obtencion y medicamentos que las contienen.
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.
DE69108319D1 (de) Verfahren zur herstellung von vitamin-d2-verbindungen und ihrer 1-alpha hydrogenierten derivate.
FR2412550A1 (fr) Derives des 3-carboxyrifamycines s et sv, procede pour leur preparation, et leur application en tant que medicaments

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920917

FG3A Patent granted, date of granting

Effective date: 19990312

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020930